<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02742077</url>
  </required_header>
  <id_info>
    <org_study_id>2016-01</org_study_id>
    <nct_id>NCT02742077</nct_id>
  </id_info>
  <brief_title>Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II</brief_title>
  <acronym>RAPID II</acronym>
  <official_title>CorPath® 200 RAPID II Study (Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corindus Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corindus Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and performance of the CorPath 200 System&#xD;
      in the remote delivery and manipulation of guidewires and rapid exchange catheters for use in&#xD;
      percutaneous vascular interventions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, single-arm, single center, non-randomized feasibility study of the&#xD;
      CorPath 200 System to examine its performance during complete interventions (DCB, Stenting)&#xD;
      of the femoropopliteal arteries and patient outcomes at 30 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Success</measure>
    <time_frame>72 hours or hospital discharge, whichever comes first.</time_frame>
    <description>Defined as &lt;50% residual stenosis in all CorPath 200 System treated lesions at the completion of the interventional procedure in the absence of device-related serious adverse events (SAE).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Procedure</time_frame>
    <description>No device-related serious adverse events.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operator Radiation Exposure Dose</measure>
    <time_frame>Procedure</time_frame>
    <description>Physician operator radiation exposure as recorded on personal Enterprise Dose Dashboard (EDD; Landauer) dosimeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Radiation Exposure Dose</measure>
    <time_frame>Procedure</time_frame>
    <description>Patient Radiation Dose-area-product (DAP)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Robotic-assisted PVI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Robotic-assisted peripheral vascular intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robotic-assisted peripheral vascular intervention</intervention_name>
    <description>Remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventions.</description>
    <arm_group_label>Robotic-assisted PVI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        General Inclusion Criteria&#xD;
&#xD;
          -  At least 18 years of age;&#xD;
&#xD;
          -  Symptomatic disease: presence of critical limb ischemia (including tissue loss or rest&#xD;
             pain), or lifestyle-limiting claudication requiring intervention in the&#xD;
             femoropopliteal arteries; and&#xD;
&#xD;
          -  The subject has been informed of the nature of the study and agrees to its provisions&#xD;
             and has provided written informed consent.&#xD;
&#xD;
        Angiographic Inclusion Criteria Femoropopliteal artery lesion(s) with stenosis (&gt;50%) or&#xD;
        occlusion of up to 120 mm in length as determined by imaging (MRA or Angio) prior to index&#xD;
        interventional procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        General Exclusion Criteria&#xD;
&#xD;
        If any of the following criteria are met, the subject cannot be enrolled in this study:&#xD;
&#xD;
          -  Failure/inability/unwillingness to provide informed consent;&#xD;
&#xD;
          -  Target vessel has been previously treated with bypass; or&#xD;
&#xD;
          -  Enrolled in concurrent clinical study.&#xD;
&#xD;
        Angiographic Exclusion Criteria&#xD;
&#xD;
        • Target vessel:&#xD;
&#xD;
          -  Shows evidence of previous dissection or perforation, or&#xD;
&#xD;
          -  Has adjacent acute thrombus; or&#xD;
&#xD;
          -  Has a pre-existing target artery aneurysm or perforation or dissection of the target&#xD;
             artery prior to initiation of the interventional procedure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marianne Brodmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medizinische Universtität Graz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizinische Univeristät Graz</name>
      <address>
        <city>Graz</city>
        <zip>A-8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>April 12, 2016</study_first_submitted>
  <study_first_submitted_qc>April 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2016</study_first_posted>
  <results_first_submitted>August 20, 2020</results_first_submitted>
  <results_first_submitted_qc>August 20, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 4, 2020</results_first_posted>
  <last_update_submitted>October 13, 2020</last_update_submitted>
  <last_update_submitted_qc>October 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Robotic-assisted PVI</title>
          <description>Robotic-assisted peripheral vascular intervention: Remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventions.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Robotic-assisted PVI</title>
          <description>Robotic-assisted peripheral vascular intervention: Remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventions.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.6" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinical Success</title>
        <description>Defined as &lt;50% residual stenosis in all CorPath 200 System treated lesions at the completion of the interventional procedure in the absence of device-related serious adverse events (SAE).</description>
        <time_frame>72 hours or hospital discharge, whichever comes first.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Robotic-assisted PVI</title>
            <description>Robotic-assisted peripheral vascular intervention: Remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventions.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Success</title>
          <description>Defined as &lt;50% residual stenosis in all CorPath 200 System treated lesions at the completion of the interventional procedure in the absence of device-related serious adverse events (SAE).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Adverse Events</title>
        <description>No device-related serious adverse events.</description>
        <time_frame>Procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Robotic-assisted PVI</title>
            <description>Robotic-assisted peripheral vascular intervention: Remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventions.</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events</title>
          <description>No device-related serious adverse events.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operator Radiation Exposure Dose</title>
        <description>Physician operator radiation exposure as recorded on personal Enterprise Dose Dashboard (EDD; Landauer) dosimeters</description>
        <time_frame>Procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Robotic-assisted PVI</title>
            <description>Robotic-assisted peripheral vascular intervention: Remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventions.</description>
          </group>
        </group_list>
        <measure>
          <title>Operator Radiation Exposure Dose</title>
          <description>Physician operator radiation exposure as recorded on personal Enterprise Dose Dashboard (EDD; Landauer) dosimeters</description>
          <units>μSv</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Radiation Exposure Dose</title>
        <description>Patient Radiation Dose-area-product (DAP)</description>
        <time_frame>Procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Robotic-assisted PVI</title>
            <description>Robotic-assisted peripheral vascular intervention: Remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventions.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Radiation Exposure Dose</title>
          <description>Patient Radiation Dose-area-product (DAP)</description>
          <units>Gy•m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="566.7" spread="391.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Robotic-assisted PVI</title>
          <description>Robotic-assisted peripheral vascular intervention: Remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventions.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Access-site Hematoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Manager</name_or_title>
      <organization>Corindus, Inc.</organization>
      <phone>(757) 910-4818</phone>
      <email>tina.ridgeway@corindus.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

